Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioMarin Pharmaceutical Inc. buy Truist Financial Co.

Start price
€81.14
05.09.24 / 50%
Target price
€106.35
05.09.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 05.09.25. The prediction end date can be changed by Truist_Financial_Co_ at any time.
Performance without dividends (%)
Name 1w
BioMarin Pharmaceutical Inc. -
iShares Core DAX® -1.215%
iShares Nasdaq 100 -1.911%
iShares Nikkei 225® -3.171%
iShares S&P 500 -1.029%

Comments by Truist_Financial_Co_ for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 106.353
Change
Ends at 05.09.25

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Truist Financial Co. from $140.00 to $118.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat

Stopped prediction by Truist_Financial_Co_ for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€83.00
25.09.23
€131.92
25.09.24
-2.24%
04.09.24

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€82.68
15.09.23
€131.12
15.09.24
-1.86%
04.09.24

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€76.16
13.07.23
€125.20
13.07.24
3.31%
14.07.24